Canadians hoping to celebrate next Canada Day with a legal joint might see their summer plans go up in smoke. Conservative senators are threatening to delay marijuana legalization in Canada until the end of 2018.
Legalization of cannabis’ medicinal use is rapidly increasing worldwide, raising the need to evaluate medical implications of cannabis. Currently, evidence supports cannabis and its active ingredients as immune-modulating agents, affecting T-cells, B-cells, monocytes, and microglia cells, causing an overall reduction in pro-inflammatory cytokine expression and an increase in anti-inflammatory cytokines. Due to the supporting evidence of cannabinoids as an immune-modulating agent, research focusing on cannabinoids and autoimmunity has emerged.
Parkinson’s disease (PD), a neurodegenerative disorder, is the second most common neurological illness in United States. Neurologically, it is characterized by the selective degeneration of a unique population of cells, the nigrostriatal dopamine neurons. The current treatment is symptomatic and mainly involves replacement of dopamine deficiency. This therapy improves only motor symptoms of Parkinson’s disease and is associated with a number of adverse effects including dyskinesia. Therefore, there is unmet need for more comprehensive approach in the management of Parkinson’s disease and neurodegenerative and movement disorders. The potential for cannabis to enhance the quality of life of Parkinson’s patients is explored.
Alongside bottles of vodka, whisky and rum, marijuana will soon be stocked on the shelves of liquor stores in Nova Scotia, Canada. The provincial government announced last week that the Nova Scotia Liquor Corporation (NSLC), the province’s sole alcohol distributor, would be responsible for selling recreational marijuana in the province once Canada legalizes weed — a…
2017 is coming to a close, and unfortunately it didn’t offer up as many highlights when it comes to marijuana as 2016. Last year, we saw three states legalize cannabis recreationally (California, Maine and Massachusetts), and a fourth came up just short (Arizona). This year, the biggest story was that New Jersey elected someone who’s…
Government has upped THC levels of the drug from 2% to 9% Humans have been getting high on marijuana for millennia, and there has never been a recorded case of a fatal overdose. That record appeared to be in peril earlier this week, following reports that an 11-month-old in Colorado died last year following exposure to THC,…
Government has upped THC levels of the drug from 2% to 9% Five months after legalising recreational marijuana, there are more than 16,000 Uruguayans registered to buy the drug from pharmacies, up from 5,000 users in July. People in Uruguay can also grow plants at home, or become a member of a local Cannabis Club…
There is an explosion in the number of labs analyzing cannabinoids in marijuana (Cannabis sativa L., Cannabaceae) but existing methods are inefficient, require expert analysts. The objective of this work was to develop and validate an accurate method for analyzing cannabinoids in cannabis raw materials and finished products that is more efficient and uses fewer toxic solvents. This is a significant improvement over previous methods and is suitable for a wide range of applications including regulatory compliance, clinical studies, direct patient medical services, and commercial suppliers.
Cannabidiol (CBD)-based treatments for several diseases, including Tourette’s syndrome, multiple sclerosis, epilepsy, movement disorders and glaucoma, are proving to be beneficial and the scientific clinical background of the drug is continuously evolving. This study demonstrated the safety and tolerability of CBD-rich hemp oil and the primary efficacy endpoint. Randomized controlled trials are warranted to characterize the safety profile and efficacy of this compound.
The new bill sets out the proposed rules and regulations An act to amend the Drug Dependence (Treatment not Imprisonment) Act of 2015 will be discussed in Parliament today, and could determine the future of medical cannabis in Malta. The bill, which will be undergoing its second reading in a plenary session in Parliament this…